New research reveals that people who stop using new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who end traditional lifestyle regimens.
Findings released in a leading health publication points out that while obese individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying such medications should be cognizant of the danger of fast rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment mass within about 18 months.
Analyzing Therapies
The research, which reviewed 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers note that people who lose weight through lifestyle changes alone generally experience a slower creep back—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Experts propose the mode of action of the jabs is key to understanding the amplified weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating much more probable."
A Lifelong Condition?
Medical guidelines recommend the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, considering the high risk of relapse, the treatment might need to be long-term.
This perspective is supported by pharmaceutical companies, who state that the findings "emphasize the chronic character of excess weight," akin to managing diseases like diabetes.
User Experiences
Users who have come off the jabs explain a powerful return of hunger.
"I experienced a switch activating and you're instantly extremely hungry," said a patient.
This difficulty is worsened if individuals have not adopted permanent dietary or behavioural modifications during treatment.
Widespread Use
Figures indicate that a significant number of people in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is more common among women compared to men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while these medications are powerful agents for shedding pounds, they are not a standalone solution and maintained weight loss hinges on integrated lifestyle management.
